ImageneBio, Inc. (IMA)

ImageneBio Statistics

Total Valuation

ImageneBio has a market cap or net worth of $97.39 million. The enterprise value is $114.53 million.

Market Cap	97.39M
Enterprise Value	114.53M

Important Dates

The next estimated earnings date is Saturday, November 15, 2025, before market open.

Earnings Date	Nov 15, 2025
Ex-Dividend Date	n/a

Share Statistics

ImageneBio has 11.18 million shares outstanding.

Current Share Class	11.18M
Shares Outstanding	11.18M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-99.48%
Owned by Insiders (%)	1.42%
Owned by Institutions (%)	15.32%
Float	9.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.62
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	26.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.37

Current Ratio	0.37
Quick Ratio	0.18
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-68.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	143.65%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ImageneBio has paid $13,000 in taxes.

Income Tax	13,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.93% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-56.93%
50-Day Moving Average	9.33
200-Day Moving Average	14.14
Relative Strength Index (RSI)	58.52
Average Volume (20 Days)	98,758

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ImageneBio had revenue of $4.30 million and -$33.91 million in losses. Loss per share was -$0.09.

Revenue	4.30M
Gross Profit	4.30M
Operating Income	-21.53M
Pretax Income	-21.64M
Net Income	-33.91M
EBITDA	-21.44M
EBIT	-21.53M
Loss Per Share	-$0.09

Balance Sheet

The company has $6.02 million in cash and $23.27 million in debt, giving a net cash position of -$17.25 million or -$1.54 per share.

Cash & Cash Equivalents	6.02M
Total Debt	23.27M
Net Cash	-17.25M
Net Cash Per Share	-$1.54
Equity (Book Value)	-15.11M
Book Value Per Share	-0.43
Working Capital	-21.53M

Cash Flow

Operating Cash Flow	-25.31M
Capital Expenditures	n/a
Free Cash Flow	-25.31M
FCF Per Share	-$2.26

Margins

Gross Margin	100.00%
Operating Margin	-500.72%
Pretax Margin	-503.35%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ImageneBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-34.86%
FCF Yield	-26.02%

Analyst Forecast

The average price target for ImageneBio is $30.00, which is 244.43% higher than the current price. The consensus rating is "Buy".

Price Target	$30.00
Price Target Difference	244.43%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ImageneBio has an Altman Z-Score of -19.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.3
Piotroski F-Score	1